Koers Deltagen Inc. Other OTC
Aandelen
DGEN
US24783R1032
Farmaceutische producten
Omzet 2002 | 17,69 mln. 16,53 mln. | Omzet 2003 * | - | Marktkapitalisatie | 17,48 mln. 16,34 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2002 | -107 mln. -99,98 mln. | Nettowinst (verlies) 2003 * | - | EV/omzet 2002 | 1,21 x |
Nettoschuld 2002 | 1,75 mln. 1,63 mln. | Nettoliquiditeiten 2003 * | - 0 | EV/omzet 2003 * | - |
K/w-verhouding 2002 |
-0,17
x | K/w-verhouding 2003 * |
-
| Werknemers | - |
Dividendrendement 2002 * |
-
| Dividendrendement 2003 * |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Driscoll
CEO | Chief Executive Officer | - | 01-01-99 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Driscoll
CEO | Chief Executive Officer | - | 01-01-99 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,74% | 1,09 mld. | |
-13,69% | 60,39 mln. |